Frank Halley

1.0k total citations
20 papers, 462 citations indexed

About

Frank Halley is a scholar working on Molecular Biology, Organic Chemistry and Computational Theory and Mathematics. According to data from OpenAlex, Frank Halley has authored 20 papers receiving a total of 462 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 10 papers in Organic Chemistry and 3 papers in Computational Theory and Mathematics. Recurrent topics in Frank Halley's work include Computational Drug Discovery Methods (3 papers), PI3K/AKT/mTOR signaling in cancer (3 papers) and Chemical Synthesis and Analysis (2 papers). Frank Halley is often cited by papers focused on Computational Drug Discovery Methods (3 papers), PI3K/AKT/mTOR signaling in cancer (3 papers) and Chemical Synthesis and Analysis (2 papers). Frank Halley collaborates with scholars based in France, United States and United Kingdom. Frank Halley's co-authors include Derek H. R. Barton, Nubar Ozbalik, Jean‐Pierre Finet, Charles Giannotti, Iain M. McLay, G.G.A. Balavoine, Martine Schmitt, John E. Souness, Alan Collis and Jeffrey M. McKenna and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Medicinal Chemistry and Tetrahedron.

In The Last Decade

Frank Halley

20 papers receiving 439 citations

Peers

Frank Halley
Noel S. Wilson United States
Premji Meghani United Kingdom
Yi‐Yin Ku United States
William A. Metz United States
Les A. Dakin United States
Margaret A. McCarrick United States
Bryan Roberts United Kingdom
Noel S. Wilson United States
Frank Halley
Citations per year, relative to Frank Halley Frank Halley (= 1×) peers Noel S. Wilson

Countries citing papers authored by Frank Halley

Since Specialization
Citations

This map shows the geographic impact of Frank Halley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank Halley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank Halley more than expected).

Fields of papers citing papers by Frank Halley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frank Halley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank Halley. The network helps show where Frank Halley may publish in the future.

Co-authorship network of co-authors of Frank Halley

This figure shows the co-authorship network connecting the top 25 collaborators of Frank Halley. A scholar is included among the top collaborators of Frank Halley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frank Halley. Frank Halley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vincent, Loı̈c, Mikhail Levit, Frank Halley, et al.. (2016). Concomitant Inhibition of PI3Kβ and BRAF or MEK in PTEN-Deficient/ BRAF -Mutant Melanoma Treatment: Preclinical Assessment of SAR260301 Oral PI3K β -Selective Inhibitor. Molecular Cancer Therapeutics. 15(7). 1460–1471. 17 indexed citations
2.
Robinson, Daniel P., Thomas Bertrand, Jean‐Christophe Carry, et al.. (2016). Differential Water Thermodynamics Determine PI3K-Beta/Delta Selectivity for Solvent-Exposed Ligand Modifications. Journal of Chemical Information and Modeling. 56(5). 886–894. 29 indexed citations
3.
Leriche, Caroline, et al.. (2015). Preparation and optimization of pyrazolo[1,5-a]pyrimidines as new potent PDE4 inhibitors. Bioorganic & Medicinal Chemistry Letters. 26(2). 454–459. 24 indexed citations
4.
Certal, Victor, Frank Halley, Angéla Virone-Oddos, et al.. (2014). Preparation and optimization of new 4-(2-(indolin-1-yl)-2-oxoethyl)-2-morpholinothiazole-5-carboxylic acid and amide derivatives as potent and selective PI3Kβ inhibitors. Bioorganic & Medicinal Chemistry Letters. 24(6). 1506–1510. 5 indexed citations
5.
Lesuisse, Dominique, Gilles Tiraboschi, Matthias Dreyer, et al.. (2010). Rational design of potent GSK3β inhibitors with selectivity for Cdk1 and Cdk2. Bioorganic & Medicinal Chemistry Letters. 20(6). 1985–1989. 21 indexed citations
6.
Lesuisse, Dominique, Gilles Tiraboschi, Pierre-Yves Abécassis, et al.. (2010). Design of potent and selective GSK3β inhibitors with acceptable safety profile and pharmacokinetics. Bioorganic & Medicinal Chemistry Letters. 20(7). 2344–2349. 8 indexed citations
7.
McKenna, Jeffrey M., Frank Halley, John E. Souness, et al.. (2002). An Algorithm-Directed Two-Component Library Synthesized Via Solid-Phase Methodology Yielding Potent and Orally Bioavailable p38 MAP Kinase Inhibitors. Journal of Medicinal Chemistry. 45(11). 2173–2184. 53 indexed citations
8.
Collis, Alan, Martyn Foster, Frank Halley, et al.. (2001). RPR203494 a pyrimidine analogue of the p38 inhibitor RPR200765A with an improved in vitro potency. Bioorganic & Medicinal Chemistry Letters. 11(5). 693–696. 33 indexed citations
9.
Astles, Peter C., Thomas J. Brown, Frank Halley, et al.. (2000). Selective ETAAntagonists. 5. Discovery and Structure−Activity Relationships of Phenoxyphenylacetic Acid Derivatives. Journal of Medicinal Chemistry. 43(5). 900–910. 32 indexed citations
10.
Booker‐Milburn, Kevin I., et al.. (2000). Fe(III)/Cu(II) mediated 5- and 6-exo oxidative ring expansion/cyclisation of cyclopropyl ethers: studies towards dictyol C and α-eudesmol. Tetrahedron Letters. 41(23). 4651–4655. 9 indexed citations
11.
Brown, Thomas J., Paul Alan Cox, Frank Halley, et al.. (1998). Identification of a non peptidic RANTES antagonist. Bioorganic & Medicinal Chemistry Letters. 8(7). 771–774. 9 indexed citations
12.
Astles, Peter C., Thomas J. Brown, Frank Halley, et al.. (1998). Selective Endothelin A Receptor Antagonists. 4. Discovery and Structure−Activity Relationships of Stilbene Acid and Alcohol Derivatives. Journal of Medicinal Chemistry. 41(15). 2745–2753. 12 indexed citations
13.
Astles, Peter C., Thomas J. Brown, Paul Alan Cox, et al.. (1997). New non peptidic C5a receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 7(7). 907–912. 17 indexed citations
14.
Halley, Frank, et al.. (1997). Synthesis of 5-Cyanoindazole and 1-Methyl and 1-Aryl-5-Cyanoindazoles. Synthetic Communications. 27(7). 1199–1207. 9 indexed citations
15.
Ashton, Michael J., Thomas J. Brown, Garry Fenton, et al.. (1996). New Low-Density Lipoprotein Receptor Upregulators Acting via a Novel Mechanism. Journal of Medicinal Chemistry. 39(17). 3343–3356. 8 indexed citations
16.
Bridge, Andrew W., Garry Fenton, Frank Halley, et al.. (1993). Synthesis of 1,3-disubstituted-pyrrolo[2,1-a]isoquinoline-2-carboxylic acids, esters and amides. Journal of the Chemical Society Perkin Transactions 1. 2761–2761. 8 indexed citations
17.
Barton, Derek H. R., et al.. (1989). Functionalization of saturated hydrocarbons. 14. Further studies on the mechanism of Gif-type systems. Journal of the American Chemical Society. 111(18). 7144–7149. 86 indexed citations
18.
Barton, Derek H. R., et al.. (1989). Benzylic oxidation by the gifIV system. Tetrahedron Letters. 30(48). 6615–6618. 15 indexed citations
19.
Barton, Derek H. R., Jean‐Pierre Finet, Charles Giannotti, & Frank Halley. (1988). The chemistry of pentavalent organobismuth reagents. Tetrahedron. 44(14). 4483–4494. 18 indexed citations
20.
Barton, Derek H. R., Jean‐Pierre Finet, Charles Giannotti, & Frank Halley. (1987). The chemistry of pentavalent organobismuth reagents. Part 7. The possible role of radical mechanisms in the phenylation process for bismuth(V), and related lead(IV), lodine(III), and antimony(V) reagents. Journal of the Chemical Society Perkin Transactions 1. 241–241. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026